These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 18644943)
1. Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is necessary. Pandolfini C; Bonati M Arch Dis Child; 2008 Aug; 93(8):715. PubMed ID: 18644943 [No Abstract] [Full Text] [Related]
2. European paediatric research and children's therapeutic needs. A trial review. Pandolfini C; Bonati M Acta Paediatr; 2008 Sep; 97(9):1232-7. PubMed ID: 18489618 [TBL] [Abstract][Full Text] [Related]
3. [European network for investigation of medicinal products in children (Medichildren)]. Pons G Arch Pediatr; 2006 Jun; 13(6):631. PubMed ID: 16713209 [No Abstract] [Full Text] [Related]
4. Pediatric medicine. Europe follows U.S. in testing drugs for children. Bosch X Science; 2005 Sep; 309(5742):1799. PubMed ID: 16166486 [No Abstract] [Full Text] [Related]
5. [Network for investigation of medicinal products in children]. Kassaï B; Treluyer JM; Jacqz-Aigrain E; Pons G Arch Pediatr; 2006 Jun; 13(6):631-4. PubMed ID: 16697606 [No Abstract] [Full Text] [Related]
6. [Children on the drug development map. The Danish Society of Clinical Pharmacology]. Thirstrup S; Heisterberg J; Ugeskr Laeger; 2008 Mar; 170(12):1039. PubMed ID: 18397657 [No Abstract] [Full Text] [Related]
8. European regulatory authorities and pediatric labeling. Autret E Pediatrics; 1999 Sep; 104(3 Pt 2):614-8. PubMed ID: 10469802 [No Abstract] [Full Text] [Related]
9. [Great risks of undertreatment. Two of three hospitalized children are not receiving approved drug treatment]. Orn P Lakartidningen; 2000 Feb; 97(7):685-7. PubMed ID: 10740374 [No Abstract] [Full Text] [Related]
10. [Pediatric pharmacology: is treatment of children preceded by an adequate investigation?]. Rubio González A; Suárez Ochoa J; Azanza Perea J; Honorato Pérez J An Esp Pediatr; 1989 May; 30(5):359-62. PubMed ID: 2667410 [TBL] [Abstract][Full Text] [Related]
11. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs]. Johannesson M; Berglund EG Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388 [No Abstract] [Full Text] [Related]
12. [New EU law--an improvement for Norwegian children?]. Kalikstad B Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1770-2. PubMed ID: 19756062 [No Abstract] [Full Text] [Related]
13. EU law mandates drug testing in children. Sinha G J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609 [No Abstract] [Full Text] [Related]
15. Drug development for children: how adequate is the current European ethical guidance? Westra AE; Engberts DP; Sukhai RN; Wit JM; de Beaufort ID Arch Dis Child; 2010 Jan; 95(1):3-6. PubMed ID: 19321505 [No Abstract] [Full Text] [Related]
16. Pediatric study of medicines becomes mandatory. Bonetta L Nat Med; 2000 Oct; 6(10):1069. PubMed ID: 11017118 [No Abstract] [Full Text] [Related]
17. Regulatory aspects of clinical trials in children. Mentzer D Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():203-7; discussion 207-9. PubMed ID: 20799462 [TBL] [Abstract][Full Text] [Related]
18. Data protection: an anti-generic weapon. Prescrire Int; 2003 Dec; 12(68):235. PubMed ID: 14986701 [No Abstract] [Full Text] [Related]
19. Optimal sampling theory: An overview of its application to pharmacokinetic studies in infants and children. Reed MD Pediatrics; 1999 Sep; 104(3 Pt 2):627-32. PubMed ID: 10469805 [No Abstract] [Full Text] [Related]